It’s Nobel Prize season—the time of year when scientists speculate who among them will receive one of the most coveted awards ...

The venture capital firm Atlas Venture is launching a start-up that aims to develop antisense oligonucleotides for a ...

Victor Ambros and Gary Ruvkunreceive prize for the discovery of microRNA and its role in post-transcriptional gene regulation ...

As drug companies fret over their finances, they are increasingly partnering with universities to help with early-stage ...

Though the topic seems mundane, Jensen tells Newscripts the science is broadly applicable—everyone gets paper cuts—and ...